Lasers & photonics
Pilot production
Developing a medical device from the initial idea or concept through to full-scale production is a challenging task for any company, but especially for SMEs or start-ups developing their fi rst product. In the case of photonics, MedPhab, Europe’s fi rst pilot line for medical devices, can help companies accelerate the time between concept and production. Jussi Hiltunen, research professor at VTT Technical Research Centre of Finland, as well as MedPhab coordinator, explains how MedPhab’s combination of technology and expertise helps product developers bring their ideas to market.
I
n the field of photonics, delays in product development are frequently caused by the heterogeneous nature of photonic technologies and the fragmented offerings of supply companies. Consequently, the more widespread use of photonics in scattered ecosystems presents major challenges for both end-user companies and manufacturers. To make things more difficult, meeting regulatory compliance can be a challenge when establishing a full supply chain to cover all the required technologies in a product. MedPhab is a consortium of research organisations, as well as industry partners, which aims to bridge the gaps in knowledge frequently seen in these areas and accelerate medical photonic product development by establishing a sustainable open access pilot line. The challenge we are addressing is the complex nature of the different technologies and types of organisations needed to advance medical photonic products and applications. Manufacturers are responsible for an entire spectrum of development, production and life cycle management. So MedPhab’s approach is to have a single-entry point to access the
62
whole consortium. At the front end, manufacturers can describe their challenge, which is then assessed by medical device professionals, who guide them to the right partners. Depending on the maturity of the development phase and the required technologies, MedPhab can assign both research organisations and industrial supply companies with ISO13485 certification to work together to deliver for customers. Once the appropriate partners are selected, challenges are broken down according to a standard way of working, allowing them to be addressed in a structured way. This enables a swift delivery of tangible and transferable bodies of work and clear next steps towards a solution. MedPhab has been developed to provide a comprehensive source of relevant knowledge for photonic medical device development, to maintain this ecosystem and to facilitate easy access to these resources.
Structured way of working The structured way of working in the consortium allows us to streamline a development request based
Medical Device Developments /
www.nsmedicaldevices.com
Agor2012/
Shutterstock.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128
